Nasal ganglioglioma

Nasal ganglioglioma is an extremely rare congenital benign tumor arising within the nasal cavity. It is classified among developmental malformations of the nose and is composed of both neuronal (ganglion cell) and glial cell elements, distinguishing it from simple nasal gliomas which contain only glial tissue. The condition is typically present at birth or identified in early infancy and is thought to result from ectopic central nervous system tissue that becomes sequestered in the nasal region during embryological development. It is classified under congenital malformations of the nose (ICD-10: Q30.8). Clinically, nasal ganglioglioma presents as a mass within the nasal cavity that may cause nasal obstruction, difficulty breathing through the nose, and occasionally feeding difficulties in neonates. The mass is typically firm, non-compressible, and does not transilluminate. Unlike encephaloceles, nasal gangliogliomas generally do not have an intracranial connection, though imaging studies (MRI or CT) are essential to rule out any communication with the central nervous system before intervention. Treatment is primarily surgical excision of the mass. Complete surgical removal is generally curative, and the prognosis is excellent, as these tumors are benign and rarely recur after complete resection. Multidisciplinary evaluation involving otolaryngology, neurosurgery, and radiology is recommended to plan the surgical approach and ensure there is no intracranial extension. Long-term follow-up may be advised to monitor for any recurrence.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Nasal ganglioglioma